First Time Loading...

Medicover AB
OTC:MCVEF

Watchlist Manager
Medicover AB Logo
Medicover AB
OTC:MCVEF
Watchlist
Price: 12.25 USD Market Closed
Updated: May 7, 2024

Intrinsic Value

Medicover AB engages in the provision of invitro diagnostics and healthcare services. [ Read More ]

The intrinsic value of one MCVEF stock under the Base Case scenario is 22.47 USD. Compared to the current market price of 12.25 USD, Medicover AB is Undervalued by 45%.

Key Points:
MCVEF Intrinsic Value
Base Case
22.47 USD
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medicover AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MCVEF stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Medicover AB

Provide an overview of the primary business activities
of Medicover AB.

What unique competitive advantages
does Medicover AB hold over its rivals?

What risks and challenges
does Medicover AB face in the near future?

Summarize the latest earnings call
of Medicover AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medicover AB.

Provide P/S
for Medicover AB.

Provide P/E
for Medicover AB.

Provide P/OCF
for Medicover AB.

Provide P/FCFE
for Medicover AB.

Provide P/B
for Medicover AB.

Provide EV/S
for Medicover AB.

Provide EV/GP
for Medicover AB.

Provide EV/EBITDA
for Medicover AB.

Provide EV/EBIT
for Medicover AB.

Provide EV/OCF
for Medicover AB.

Provide EV/FCFF
for Medicover AB.

Provide EV/IC
for Medicover AB.

Show me price targets
for Medicover AB made by professional analysts.

What are the Revenue projections
for Medicover AB?

How accurate were the past Revenue estimates
for Medicover AB?

What are the Net Income projections
for Medicover AB?

How accurate were the past Net Income estimates
for Medicover AB?

What are the EPS projections
for Medicover AB?

How accurate were the past EPS estimates
for Medicover AB?

What are the EBIT projections
for Medicover AB?

How accurate were the past EBIT estimates
for Medicover AB?

Compare the revenue forecasts
for Medicover AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medicover AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medicover AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medicover AB compared to its peers.

Compare the P/E ratios
of Medicover AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Medicover AB with its peers.

Analyze the financial leverage
of Medicover AB compared to its main competitors.

Show all profitability ratios
for Medicover AB.

Provide ROE
for Medicover AB.

Provide ROA
for Medicover AB.

Provide ROIC
for Medicover AB.

Provide ROCE
for Medicover AB.

Provide Gross Margin
for Medicover AB.

Provide Operating Margin
for Medicover AB.

Provide Net Margin
for Medicover AB.

Provide FCF Margin
for Medicover AB.

Show all solvency ratios
for Medicover AB.

Provide D/E Ratio
for Medicover AB.

Provide D/A Ratio
for Medicover AB.

Provide Interest Coverage Ratio
for Medicover AB.

Provide Altman Z-Score Ratio
for Medicover AB.

Provide Quick Ratio
for Medicover AB.

Provide Current Ratio
for Medicover AB.

Provide Cash Ratio
for Medicover AB.

What is the historical Revenue growth
over the last 5 years for Medicover AB?

What is the historical Net Income growth
over the last 5 years for Medicover AB?

What is the current Free Cash Flow
of Medicover AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medicover AB.

Financials

Balance Sheet Decomposition
Medicover AB

Current Assets 381.3m
Cash & Short-Term Investments 64.4m
Receivables 257.5m
Other Current Assets 59.4m
Non-Current Assets 1.6B
Long-Term Investments 17.2m
PP&E 875.7m
Intangibles 639.2m
Other Non-Current Assets 27.9m
Current Liabilities 500.6m
Accounts Payable 204.6m
Other Current Liabilities 296m
Non-Current Liabilities 944.2m
Long-Term Debt 774.6m
Other Non-Current Liabilities 169.6m
Efficiency

Earnings Waterfall
Medicover AB

Revenue
1.7B EUR
Cost of Revenue
-1.4B EUR
Gross Profit
359.4m EUR
Operating Expenses
-297.5m EUR
Operating Income
61.9m EUR
Other Expenses
-44.3m EUR
Net Income
17.6m EUR

Free Cash Flow Analysis
Medicover AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MCVEF Profitability Score
Profitability Due Diligence

Medicover AB's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
50/100
Profitability
Score

Medicover AB's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

MCVEF Solvency Score
Solvency Due Diligence

Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Average D/E
Short-Term Solvency
41/100
Solvency
Score

Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MCVEF Price Targets Summary
Medicover AB

Wall Street analysts forecast MCVEF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCVEF is 14.19 USD .

Lowest
Price Target
Not Available
Average
Price Target
14.19 USD
16% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MCOV B Price
Medicover AB

1M 1M
+29%
6M 6M
+37%
1Y 1Y
+4%
3Y 3Y
-22%
5Y 5Y
+122%
10Y 10Y
+180%
Annual Price Range
183
52w Low
121.1
52w High
183
Price Metrics
Average Annual Return 34.57%
Standard Deviation of Annual Returns 71.41%
Max Drawdown -70%
Shares Statistics
Market Capitalization 27.4B SEK
Shares Outstanding 149 652 400
Percentage of Shares Shorted
N/A

MCOV B Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Medicover AB Logo
Medicover AB

Country

Sweden

Industry

Health Care

Market Cap

27.4B SEK

Dividend Yield

1.06%

Description

Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 38,555 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.

Contact

STOCKHOLM
Stockholm
Riddargatan 12 A 3Tr
+468446461764646.0
https://www.medicover.com

IPO

2017-05-23

Employees

38 555

Officers

CEO & Director
Mr. Fredrik Rågmark
Chief Financial Officer
Mr. Joe Ryan
Chief Information Officer
Mr. Jaroslaw Urbanczyk
Head of Investor Relations
Hanna Bjellquist
General Legal Counsel
Ms. Jenny Brandt
Chief Marketing Officer
Dr. Andrew Vallance-Owen FRCS Ed, MBA
Show More
Group Chief People Officer
Ms. Kamila Skorupinski
Chief Operating Officer of Healthcare Services
Mr. John Paul Stubbington
Chief Operating Officer for Diagnostic Services
Mr. Staffan Ternstrom
Show Less

See Also

Discover More
What is the Intrinsic Value of one MCVEF stock?

The intrinsic value of one MCVEF stock under the Base Case scenario is 22.47 USD.

Is MCVEF stock undervalued or overvalued?

Compared to the current market price of 12.25 USD, Medicover AB is Undervalued by 45%.